GLP-1 receptor agonists (GLP-1RAs) have emerged as influential agents in managing type 2 diabetes mellitus (T2DM), not only for their primary role in glycemic control but also for their beneficial effects on body weight and cardiovascular risk factors. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.